Drug or technology
6 developments in the corpus
Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.
Latest
Everything in the corpus, newest first.
SEP 10, 2026 · JOURNAL ARTICLE
Frontiers in Immunology
A narrative review summarizing mechanistic evidence and preclinical/early translational data on the CCL2–CCR2 axis in lung cancer, without reporting original clinical trial results or definitive clinical outcomes.
SEP 7, 2026 · JOURNAL ARTICLE
Frontiers in Immunology
A narrative review synthesizing mechanistic concepts and scattered evidence about circulating cytokines as potential biomarkers, but acknowledging inconsistency across studies and lack of validated clinical utility.
SEP 6, 2026 · JOURNAL ARTICLE
British Journal of Clinical Pharmacology
Retrospective cohort study with adjusted hazard ratios showing substantial associations between H1-antihistamine use and improved TTF and mortality in NSCLC patients on EGFR-TKIs, but observational design precludes causal inference and requires prospective confirmation.
SEP 4, 2026 · JOURNAL ARTICLE
Frontiers in Pharmacology
A narrative review synthesizing preclinical structure-activity data and early-stage clinical experience to propose design principles for CXCR4 radiotheranostics; no new primary data or comparative efficacy evidence is reported.
AUG 18, 2026 · JOURNAL ARTICLE
Diagnostic Pathology
Well-designed single-center concordance study with clear methodology and strong statistical agreement (κ=0.98) that validates interchangeability of two antibodies in routine practice, but does not establish new clinical utility or change diagnostic approach.
JUL 28, 2026 · JOURNAL ARTICLE
The Journal of Immunology
Mechanistic murine study with flow cytometry and imaging endpoints identifying a potential barrier to mRNA vaccine efficacy; results are hypothesis-generating rather than definitive for clinical practice.